Volume | 633,983 |
|
|||||
News | - | ||||||
Day High | 0.85 | Low High |
|||||
Day Low | 0.82 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Kezar Life Sciences Inc | KZR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.8378 | 0.82 | 0.85 | 0.8245 | 0.8378 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
4,575 | 633,983 | US$ 0.8315306 | US$ 527,176 | - | 0.6746 - 3.13 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:20:10 | 16 | US$ 0.8245 | USD |
Kezar Life Sciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
59.7M | 72.80M | - | 7M | -101.87M | -1.40 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Kezar Life Sciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KZR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.811 | 0.85 | 0.773 | 0.8127383 | 522,859 | 0.0135 | 1.66% |
1 Month | 0.868 | 0.897 | 0.7502 | 0.821213 | 646,226 | -0.0435 | -5.01% |
3 Months | 0.9451 | 1.135 | 0.7502 | 0.9035137 | 790,374 | -0.1206 | -12.76% |
6 Months | 0.75 | 1.135 | 0.6746 | 0.8820067 | 705,882 | 0.0745 | 9.93% |
1 Year | 2.35 | 3.13 | 0.6746 | 1.44 | 672,477 | -1.53 | -64.91% |
3 Years | 5.63 | 18.55 | 0.6746 | 6.97 | 861,907 | -4.81 | -85.36% |
5 Years | 19.78 | 21.60 | 0.6746 | 6.75 | 622,129 | -18.96 | -95.83% |
Kezar Life Sciences Description
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. |